Skip to content
HowShorted

HCW Biologics Inc. short interest in 2023

In 2023, HCW Biologics Inc.'s disclosed short interest ran from 0.07% of shares outstanding on 13 Jan 2023 to 0.02% on 29 Dec 2023, a change of -0.05 percentage points. The year's high was 0.10% on 30 Jun 2023 and its low 0.02% on 31 Oct 2023, averaging 0.06% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.77 days on 28 Apr 2023. Full history: HCW Biologics Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for HCW Biologics Inc. in 2023

2023 in figures

Start of year
0.07% (13 Jan 2023)
End of year
0.02% (29 Dec 2023)
Change
-0.05 pp
High
0.10% (30 Jun 2023)
Low
0.02% (31 Oct 2023)
Average
0.06%
Highest days to cover
4.77 (28 Apr 2023)
SEC filings marked
8

Every report in 2023

HCW Biologics Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20230.07%1.00
15 Feb 20230.05%1.00
28 Feb 20230.08%1.07
15 Mar 20230.06%1.07
31 Mar 20230.07%2.5010-K filed, results (8-K)
14 Apr 20230.08%1.71
28 Apr 20230.08%4.77
15 May 20230.04%1.2010-Q filed, results (8-K)
31 May 20230.04%1.00
15 Jun 20230.07%1.00
30 Jun 20230.10%2.37
14 Jul 20230.07%4.17
31 Jul 20230.06%2.17
15 Aug 20230.07%4.2110-Q filed, results (8-K)
31 Aug 20230.06%4.09
15 Sep 20230.06%1.79
29 Sep 20230.03%1.14
13 Oct 20230.03%2.11
31 Oct 20230.02%1.69
15 Nov 20230.06%1.0010-Q filed, results (8-K)
30 Nov 20230.06%1.57
15 Dec 20230.03%1.00
29 Dec 20230.02%1.00

See also: HCW Biologics Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.